Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice
AbstractType 2 diabetes (T2DM) is a complex disease linked to pancreatic beta-cell failure and insulin resistance. Current antidiabetic treatment regimens for T2DM include insulin sensitizers and insulin secretagogues. We have previously demonstrated that leptolide, a member of the furanocembranolides family, promotes pancreatic beta-cell proliferation in mice. Considering the beneficial effects of leptolide in diabetic mice, in this study, we aimed to address the capability of leptolide to improve insulin resistance associated with the pathology of obesity. To this end, we tested the hypothesis that leptolide should protect against fatty acid-induced insulin resistance in hepatocytes. In a time-dependent manner, leptolide (0.1 µM) augmented insulin-stimulated phosphorylation of protein kinase B (PKB) by two-fold above vehicle-treated HepG2 cells. In addition, leptolide (0.1 µM) counteracted palmitate-induced insulin resistance by augmenting by four-fold insulin-stimulated phosphorylation of PKB in HepG2 cells. In vivo, acute intraperitoneal administration of leptolide (0.1 mg/kg and 1 mg/kg) improved glucose tolerance and insulin sensitivity in lean mice. Likewise, prolonged leptolide treatment (0.1 mg/kg) in diet-induced obese mice improved insulin sensitivity. These effects were paralleled with an ~50% increased of insulin-stimulated phosphorylation of PKB in liver and skeletal muscle and reduced circulating pro-inflammatory cytokines in obese mice. We concluded that leptolide significantly improves insulin sensitivity in vitro and in obese mice, suggesting that leptolide may be another potential treatment for T2DM. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Villa-Pérez, P.; Cueto, M.; Díaz-Marrero, A.R.; Lobatón, C.D.; Moreno, A.; Perdomo, G.; Cózar-Castellano, I. Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice. Mar. Drugs 2017, 15, 289.
Villa-Pérez P, Cueto M, Díaz-Marrero AR, Lobatón CD, Moreno A, Perdomo G, Cózar-Castellano I. Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice. Marine Drugs. 2017; 15(9):289.Chicago/Turabian Style
Villa-Pérez, Pablo; Cueto, Mercedes; Díaz-Marrero, Ana R.; Lobatón, Carmen D.; Moreno, Alfredo; Perdomo, Germán; Cózar-Castellano, Irene. 2017. "Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice." Mar. Drugs 15, no. 9: 289.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.